Articles tagged with Renal Failure
A study found that pay-for-performance incentives increased home dialysis use and kidney transplant rates. The End-Stage Renal Disease Treatment Choices model did not associate these outcomes with changes in racial or socioeconomic disparities.
A groundbreaking study reveals semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic kidney disease. Semaglutide also shows improved safety and efficacy profiles.
Receiving a kidney from a deceased donor who underwent dialysis prior to donation was associated with delayed graft function, while other factors such as graft failure and death were not significantly affected. The study found no significant differences in outcomes between these two groups.
A team of researchers from City of Hope has identified novel associations between DNA methylation activity and a subsequent risk of developing kidney failure in type 1 diabetes patients. By analyzing blood samples from over 277 participants, they found stable biomarkers that remained remarkably consistent across years.
A Mayo Clinic study found that laparoscopic sleeve gastrectomy can improve the health and eligibility of patients with advanced chronic kidney disease and obesity. The procedure reduced cardiovascular risks, including diabetes and hypertension, and improved access to kidney transplantation.
Researchers discovered that known genetic variants account for a large portion of chronic kidney diseases with unknown origin. The study found that 10% of patients had pathogenic variants in CKD-causing genes, and some hereditary renal diseases could be diagnosed and treated early on to slow down disease progression.
A study found that structural racism is largely to blame for disparities in tuberculosis (TB) incidence among the U.S.-born population. Researchers analyzed national TB registry data and found that TB incidence ratios were higher for certain racial and ethnic groups, with greater relative disparities among females.
Researchers developed Smart-CKD, a computer-aided diagnostic tool integrating ultrasound data and selected clinical variables to assess renal fibrosis progression in CKD patients. The tool has excellent predictive accuracy and high clinical application value, providing a cost-effective solution for guiding patient management.
A collaborative study found that patients with end-stage renal disease who undergo weight loss surgery can experience significant improvements in BMI, hypertension, and diabetes management. This enhancement of overall health and transplant viability offers hope for previously ineligible patients.
A major new study reveals that heart attack survivors are at high risk of developing further serious health conditions, including heart failure, kidney disease, and depression. The research found that up to a third of patients developed heart or kidney failure, and 38% died within nine years.
A small, wearable ultrasound sticker can monitor organ stiffness and detect subtle changes that signal disease progression. The device has been shown to identify early signs of acute liver failure in rats and may one day help doctors diagnose internal organ failure more effectively.
A clinical trial found that an experimental drug, BI 690517, reduced albuminuria in 70% of patients when paired with a standard-care medication. The study also showed that the combination of the two drugs mitigated the risk of hyperkalemia.
A clinical trial found that the ketogenic diet improved kidney function in patients with polycystic kidney disease, contradicting the long-held belief that it's a genetic disease. The study suggests that controlling the condition through dietary changes can lead to better health outcomes.
Researchers have identified the genetic defect causing infantile cystinosis, a rare disease that shortens lifespan, and developed a protocol to differentiate stem cells into healthy kidney cells. The study suggests using CRISPR genome editing to repair the defective gene and potentially cure the disease.
A potential treatment for Haemolytic Uraemic Syndrome (HUS) has been discovered by an international team of scientists. The breakthrough found that inhibiting the complement pathway early on can successfully treat STEC-HUS, a devastating disease that can lead to life-long dialysis and death in children.
Researchers at Vanderbilt University Medical Center found that cefepime did not significantly increase the risk of kidney failure compared to piperacillin/tazobactam in critically ill patients. However, cefepime was associated with more neurological dysfunction and shorter survival rates.
New research reveals that disrupted energy production in the kidneys contributes to progressive kidney disease in diabetes. Monitoring urinary lactate levels may help predict prognosis and guide management for diabetic kidney disease.
A Duke University study found glyphosate, active in Roundup, in high levels of wells supplying drinking water to Sri Lankan communities plagued by chronic kidney disease (CKDu). Elevated fluoride and vanadium also linked to CKDu were discovered. Glyphosate's persistence in hard water poses concerns for exposure.
A recent study published in the American Journal of Kidney Diseases found that lower uromodulin levels are associated with a higher risk of developing end-stage kidney disease. Participants who experienced steeper declines in uromodulin also showed an increased risk of kidney failure.
A study of over 15,000 individuals with chronic kidney disease found that young age, Black race, and low education and income were linked to lower flu vaccine uptake. The study suggests that targeted vaccination efforts could improve uptake among those with kidney disease.
Scientists at UCSF have developed an artificial kidney that can mimic key functions of a real kidney. The bioreactor keeps kidney cells alive for up to seven days and has shown promising results in animal trials. If successful, the device could improve treatment for kidney disease, making it more effective, tolerable, and comfortable.
Researchers found that urine levels of adenine are predictive and causative biomarkers of looming progressive kidney failure in patients with diabetes. An oral therapeutic drug showed promise in mice by reducing kidney adenine levels and protecting against diabetic kidney disease.
Researchers at the University of Zurich have used AI to uncover the underlying cellular mechanism behind kidney disease in cystinosis. They identified a causal association between mTORC1 protein regulation and the disease, highlighting a promising therapeutic target.
Researchers found that acute kidney injury does not predict worsening of kidney function trajectory in patients with CKD, suggesting that pre-existing kidney disease may be a major contributor. The study recommends focusing on flattening the eGFR slope and treating proteinuria to slow CKD progression.
A new study finds that long-term disinvestment in health and wealth resources in historically redlined neighborhoods contributes to a disproportionate rate of kidney failure among Black adults. Redlining, the discriminatory federal housing policy from the 1930s, has been associated with current racial inequities in poor health outcomes.
A peer support group intervention has been shown to be feasible and acceptable among undocumented Latinx immigrants with kidney failure. The study found that the intervention built camaraderie and provided emotional support, which is particularly important for socially marginalized uninsured populations.
Researchers investigate whether pregnant mothers' exposure to toxic metals affects kidney development in their babies, which may set the stage for chronic kidney disease. The team aims to identify key combinations of metal mixtures that could have detrimental effects on developing kidneys.
Survivors of firearm injury experience chronic PTSD symptoms and poor health-related quality of life, emphasizing the need for comprehensive care. Screening for chronic kidney disease could be cost-effective for US adults starting at age 35.
Researchers review current treatment updates for systemic light chain (AL) amyloidosis, highlighting the need for early diagnosis and effective maintenance therapy. The article discusses the relationship between AL amyloidosis and monoclonal gammopathy of undetermined significance (MGUS), emphasizing the importance of regular monitoring.
Pregnant women with SLE are more likely to experience severe maternal morbidity and fetal morbidity, with higher risks of premature birth, growth restriction, and acute renal failure. The study highlights the need for informed counseling and care for patients with SLE during pregnancy.
A growing number of states have implemented policies to cover outpatient hemodialysis for undocumented immigrants with kidney failure. This expansion may be due to increased awareness of poor outcomes with emergency hemodialysis and advocacy efforts. The move towards covering dialysis in all 50 states is called for by experts, who also...
Medical University of South Carolina researchers streamlined kidney transplant evaluations to increase access for African Americans. They used telehealth and partnerships with local providers to help patients complete the evaluation process, resulting in higher numbers of African Americans beginning and completing the evaluation.
Scientists have found that antibodies targeting βII-spectrin on mesangial cells are the trigger for IgA nephropathy. This discovery enables blood-based diagnosis and may lead to improved treatments.
Researchers at Penn Medicine discovered that maintaining nicotinamide adenine dinucleotide (NAD) levels may protect against kidney disease. NAD supplements were shown to be effective in reversing NAD loss and suppressing inflammation in mouse kidneys, suggesting a potential therapeutic target for kidney disease prevention and treatment.
Researchers identified a higher rate of premature arteriovenous graft failure among African American patients undergoing dialysis access interventions. The study, published in Radiology, found that these patients were more vulnerable to experiencing early dialysis access dysfunction and failure.
A Michigan Medicine study found that hospitals with the highest stroke care designation reported significantly higher rates of stroke detection after TAVR. The study suggests that comprehensive stroke centers are better at detecting smaller strokes, but this does not necessarily mean they are finding more strokes overall.
Researchers found that a one-year increase in retinal age was associated with a 10% higher risk of incident kidney failure over 11 years. Retinal age gap, a non-invasive biomarker based on retinal imaging, may help identify people at elevated risk for kidney failure.
Scientists have identified a potential therapy to reduce the side effects of cisplatin chemotherapy, which can cause kidney toxicity and neuropathic pain. Istradefylline, an approved Parkinson's disease drug, has been found to mitigate these harmful effects while preserving cisplatin's anti-tumor properties.
A higher urine-to-plasma urea ratio is associated with faster decline in eGFR and development of kidney failure in patients with common forms of CKD. This biomarker may improve risk prediction, particularly in low-cost, easily measurable assays.
A new troponin test has been developed to help diagnose heart attacks more accurately. By detecting only large troponin molecules, the test can distinguish between heart attacks and other conditions such as renal insufficiency.
A study published in the New England Journal of Medicine found that new onset CKD rates are higher among Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations compared to white persons with diabetes. The rate declined from 8% in 2015-2016 to 6.4% in 2019-2020.
A retrospective cross-sectional study found that VA-financed hospice services were associated with higher rates of concurrent dialysis among veterans with end-stage kidney disease. Patients who received VA-financed hospice services lived approximately 43 days after stopping dialysis, compared to just four days for those who stopped dia...
A study reveals a high incidence of chronic kidney disease among adults with diabetes, particularly affecting Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino(a) groups. The rate of new onset CKD was higher in these groups by approximately 60%, 40%, 33%, and 25% compared to White persons with ...
Researchers from Osaka University found that serum albumin can prevent the formation of amyloid fibrils in dialysis patients by interfering with β2m protein clumping. Monitoring serum albumin levels may help predict and delay the onset of dialysis-related amyloidosis, a condition also linked to Alzheimer's disease.
A prespecified subgroup analysis of East Asian adults with lupus nephritis found that belimumab added to standard therapy improved kidney outcomes significantly. The study also showed no new safety concerns were raised in the subgroup.
Researchers at Washington University have developed a hydrogel system that preserves biochemistry and mechanical environments of cultured podocyte cells. This allows researchers to identify new ways to control mechanisms used by cells to heal themselves, potentially leading to therapies for currently incurable diseases.
Researchers at Brigham and Women's Hospital have developed a highly efficient method to generate human kidney cells, including principal and intercalated cell lines. This breakthrough could lead to new therapies for treating congenital abnormalities of the kidney and urinary tract, such as polycystic kidney disease.
Researchers have discovered a molecule that can suppress the development of kidney fibrosis, a condition leading to kidney failure and devastating consequences. The breakthrough could lead to the development of new drug treatments for millions of people affected by chronic kidney disease.
Researchers identified differences in PTK activity between normal and cancer kidney tissue, with Src family kinases and PI3K pathways exhibiting high activity. Ex vivo treatment of clear cell RCC with TKIs revealed that tivozanib and cabozantinib were more potent inhibitors than sunitinib or pazopanib.
Higher aldosterone concentrations are associated with lower eGFR, lower potassium levels in blood, and higher potassium and protein concentrations in urine. The risk of CKD worsening was independent of diabetes status. Finerenone may help prevent CKD progression by targeting aldosterone's action.
A new USC analysis found that the largest Medicare Advantage plans pay 27% more for outpatient dialysis treatment compared to traditional Medicare. This significant markup is attributed to the consolidation of the dialysis industry, with two large chains supplying over three-quarters of all dialysis services in the US.
A recent review article highlights the crucial role of macrophages in the progression from acute kidney injury (AKI) to chronic kidney disease (CKD). The study suggests that targeting specific signaling pathways and altering macrophage activation can prevent renal fibrosis and CKD. Therapeutic strategies such as clodronate liposomes an...
A novel AI-empowered robotic device successfully assisted in percutaneous nephrolithotomy—surgery for removing large kidney stones. The trial showed improved precision and reduced complications, with a significant reduction in needle punctures and puncture duration.
A study found that US adults receiving hemodialysis with high air pollution exposure have more heart attacks and strokes compared to those with low exposure. The strongest associations were noted among patients who were Asian, older, or had chronic lung disease at dialysis initiation.
A large randomized controlled trial found that treatment with methylprednisolone reduces the risk of kidney function loss and failure in patients with IgA nephropathy. The study's results suggest a lower dose regimen may be effective while minimizing side effects.
A new study found that Black kidney transplant recipients exhibit a faster clearance rate of tacrolimus, an immunosuppressive drug. The study suggests that considering both sex and race when dosing tacrolimus may reduce adverse effects and enhance transplant outcomes.
Researchers at The University of Toledo found that low-dose lithium acts as a powerful anti-aging agent in the kidneys by blocking GSK3-beta, an enzyme associated with cellular aging. Studies showed improved kidney function and reduced albuminuria in mice and psychiatric patients treated with lithium.
A new study used a virtual population to simulate a clinical trial examining kidney damage in Black Americans. The model predicted kidney damage and showed that adding drug therapy and reducing salt intake could stop the damage, improving heart sizes as well.
Researchers found that impaired kidney function is preferentially associated with cardioembolic stroke in a large cohort of patients. Low filtration rates and high urine protein levels predicted increased risk of cardioembolic stroke, disability, and mortality.
A study at Duke-NUS Medical School found that inhibiting IL-11 can reduce kidney damage, inflammation, and scarring in Alport syndrome mice. Combining this therapy with ACEi treatment increased lifespan by over 400%.